Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04920383
Title ALPN-202 With PD-1 Inhibition in Advanced Malignancies (NEON-2)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Alpine Immune Sciences, Inc.

non-Hodgkin lymphoma

Advanced Solid Tumor

Hodgkin's lymphoma


ALPN-202 + unspecified PD-1 antibody

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.